Clinical Supply Chain Coordinator

San Diego · On-site$70k – $90k

About this role

Description

The Clinical Supply Chain Coordinator position will support the day-to-day execution of clinical supply chain activities. The Clinical Supply Chain Coordinator will support GMP inventory tracking, clinical labeling and packaging coordination, shipment monitoring, and documentation control. The role will work cross-functionally with Quality, Manufacturing, Clinical Operations, and external vendors. The Clinical Supply Chain Coordinator will assist the broader Clinical Supply Chain team in maintaining accurate, audit-ready records and supporting the timely, compliant flow of clinical trial materials across studies from early development through late-stage trials.

Essential Duties and Responsibilities

The main responsibilities of this role include but are not limited to the following:

  • Coordinate day-to-day clinical supply activities across active studies under the direction of the Manager, Clinical Supply Chain.
  • Track clinical material inventory levels, expiry dates, and resupply needs, and flag potential shortages or risks to the Manager.
  • Prepare supply forecasts, shipment schedules, and status reports for cross-functional teams.
  • Coordinate meeting logistics, action item tracking, and follow-up communications for supply chain planning meetings.
  • Support the review and filing of clinical labels, packaging configurations, master batch records, and distribution documentation.
  • Maintain accurate, lot- and kit-level traceability records for investigational and auxiliary materials.
  • Reconcile GMP inventory across CMOs and clinical depots, escalating discrepancies as needed.
  • Maintain documentation that is organized, complete, and inspection-ready.
  • Coordinate with CMOs, packaging/labeling partners, depots, and couriers on routine shipment and scheduling activities.
  • Track vendor deliverables and shipment status, escalating delays or issues to the Manager, Clinical Supply Chain.
  • Assist in monitoring temperature-controlled shipments and support investigation of excursions or deviations under guidance.
  • Maintain vendor contact lists, shipping schedules, and standard operating procedures.
  • Support day-to-day monitoring of the IRT/RTSM system, including kit inventory status and resupply alerts.
  • Assist in verifying kit numbers, expiration data, and depot-to-site allocations for accuracy.
  • Facilitate discrepancies or system issues to the Manager, Clinical Supply Chain for resolution.
  • Support maintenance of clinical supply chain SOPs and work instructions.
  • Collaborate with QA on documentation requests and audit preparation activities.
  • Compile supply-related content for regulatory submissions as directed.
  • Other duties as assigned.

Requirements

Education and Experience

  • B.S. in Life Sciences, Supply Chain Management, or a related discipline.
  • 2+ years of relevant experience in supply chain, logistics, or clinical operations, with internship or co-op experience in a pharmaceutical or biotechnology setting considered a plus.

Knowledge and Skills

  • Familiarity with GMP/GDP concepts is a plus.
  • Strong organizational skills and attention to detail, with the ability to manage multiple tasks and deadlines.
  • Strong computer skills with Microsoft Office (Excel, Word, PowerPoint) and the ability to quickly learn new applications.
  • Excellent written and verbal communication skills.
  • Ability to work effectively in a fast-paced, cross-functional environment with changing priorities.
  • Team player who takes initiative, follows direction well, and is eager to learn.
  • Experience with inventory management systems or IRT/RTSM platforms is a plus.

VIKING THERAPEUTICS

Viking Therapeutics, Inc., is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Viking Therapeutics also complies with all applicable national, state and local laws governing nondiscrimination in employment as well as work authorization and employment eligibility verification requirements of the Immigration and Nationality Act and IRCA.  

Notice to Agency and Search Firm Representatives

Viking Therapeutics, Inc. is not accepting unsolicited resumes from agencies and/or search firms for this job posting. Resumes submitted to any Viking employee by a third-party agency and/or search firm without a valid written & signed search agreement, and assignment of specific position, will become the sole property of Viking Therapeutics, Inc. No fee will be paid if a candidate is hired for this position as a result of an unsolicited agency or search firm referral.  

Salary Description

$70,000.00 - $90,000.00 annual salary

Company at a glance

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel first-in-class or best-in-class therapies for the treatment of metabolic and endocrine disorders. Viking's research and development activities leverage its expertise in metabolism to develop innovative therapeutics designed to improve patients' lives. Viking's clinical programs include VK2735, a novel dual agonist of the glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptors for the potential treatment of various metabolic disorders. The company is evaluating its subcutaneous formulation of VK2735 in a Phase 3 obesity program that includes two Phase 3 clinical trials (VANQUISH-1 and VANQUISH-2). Data from a Phase 1 and a Phase 2 trial evaluating subcutaneous VK2735 demonstrated an encouraging safety and tolerability profile as well as positive signs of clinical benefit. Concurrently, the company is evaluating an oral formulation of VK2735 in obesity. Viking is also developing VK2809, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the treatment of lipid and metabolic disorders. The compound successfully achieved both the primary and secondary endpoints in a Phase 2b study for the treatment of biopsy-confirmed non-alcoholic steatohepatitis (NASH) and fibrosis. The company's newest program is evaluating a series of internally developed dual amylin and calcitonin receptor agonists (or DACRAs) for the treatment of obesity and other metabolic disorders. In the rare disease space, Viking is developing VK0214, a novel, orally available, small molecule selective thyroid hormone receptor beta agonist for the potential treatment of X-linked adrenoleukodystrophy (X-ALD).

Founded2012
Team Size51-200 employees
WorkspaceOn-site
IndustryPharmaceutical Manufacturing
Location
San Diego, California, United States

Tired of cold applications?

Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.

Know someone who'd be great for this?